← Back to Search

regional anesthesia bupivacaine for Femoroacetabular Impingement

N/A
Waitlist Available
Led By Ajay Aggarwal, MD
Research Sponsored by University of Missouri-Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately post-op (while in pacu, on average 1-4 hours total)
Awards & highlights
Approved for 10 Other Conditions
All Individual Drugs Already Approved

Summary

The purpose of this research is to determine differences in outcomes in patients who receive regional anesthesia (a fascia iliaca block) versus placebo prior to undergoing hip arthroscopy with labral repair and/or debridement and osteoplasty for hip impingement.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately post-op (while in pacu, on average 1-4 hours total)
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately post-op (while in pacu, on average 1-4 hours total) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Subject log to record number of pain pills taken by subject for 7 days
Secondary study objectives
HOOS (hip disability and osteoarthritis outcome score)
Harris Hip score
Record of Pain Medication given in PACU
+3 more

Awards & Highlights

Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: regional anesthesia bupivacaineActive Control1 Intervention
regional anesthesia (a single shot fascia iliaca block using bupivacaine) prior to hip arthroscopy
Group II: regional anesthesia placeboPlacebo Group1 Intervention
subcutaneous injection procedure placebo (0.9% sodium chloride in water)

Find a Location

Who is running the clinical trial?

University of Missouri-ColumbiaLead Sponsor
377 Previous Clinical Trials
628,689 Total Patients Enrolled
Ajay Aggarwal, MDPrincipal InvestigatorUniversity of Missouri Health System
2 Previous Clinical Trials
367 Total Patients Enrolled
~0 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top